These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 17571583

  • 1. [Hepatitis B virus reactivation in patients with HBs antibodies after allogeneic hematopoietic stem cell transplantation].
    Fujimaki K, Nakaseko C, Oshima K, Sakai M, Chou R, Kanda Y, Nishimura M, Kanamori H, Sakamaki H.
    Rinsho Ketsueki; 2007 May; 48(5):386-90. PubMed ID: 17571583
    [Abstract] [Full Text] [Related]

  • 2. Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor.
    Knöll A, Boehm S, Hahn J, Holler E, Jilg W.
    J Viral Hepat; 2007 Jul; 14(7):478-83. PubMed ID: 17576389
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
    Giaccone L, Festuccia M, Marengo A, Resta I, Sorasio R, Pittaluga F, Fiore F, Boccadoro M, Rizzetto M, Bruno B, Marzano A.
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):809-17. PubMed ID: 20060484
    [Abstract] [Full Text] [Related]

  • 4. High risk of hepatitis B-virus reactivation after hematopoietic cell transplantation in hepatitis B core antibody-positive patients.
    Matsue K, Aoki T, Odawara J, Fujiwara H, Iwama K, Kimura S, Yamakura M, Takeuch M.
    Eur J Haematol; 2009 Oct; 83(4):357-64. PubMed ID: 19508685
    [Abstract] [Full Text] [Related]

  • 5. [Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation].
    Woo SY, Cho SH, Lee SM, Koh MB, Noh CH, Kim CW, Choi JY, Yang JM, Han JY, Lee YS.
    Korean J Hepatol; 2009 Jun; 15(2):131-9. PubMed ID: 19581765
    [Abstract] [Full Text] [Related]

  • 6. Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation.
    Hammond SP, Borchelt AM, Ukomadu C, Ho VT, Baden LR, Marty FM.
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1049-59. PubMed ID: 19660717
    [Abstract] [Full Text] [Related]

  • 7. Changes in serologic markers of hepatitis B following autologous hematopoietic stem cell transplantation.
    Uhm JE, Kim K, Lim TK, Park BB, Park S, Hong YS, Lee SC, Hwang IG, Koh KC, Lee MH, Ahn JS, Kim WS, Jung CW, Kang WK.
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):463-8. PubMed ID: 17382252
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis B virus infection in allogeneic bone marrow transplantation.
    Ustün C, Koç H, Karayalcin S, Akyol G, Gürman G, Ilhan O, Akan H, Ozcan M, Arslan O, Konuk N, Uysal A, Beksaç M.
    Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543
    [Abstract] [Full Text] [Related]

  • 9. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
    Chen H, Huang XJ, Liu KY, Xu LP, Wang H, Liu DH, Lu J, Lu DP.
    Zhonghua Yi Xue Za Zhi; 2005 Nov 16; 85(43):3062-6. PubMed ID: 16324408
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host disease.
    Seth P, Alrajhi AA, Kagevi I, Chaudhary MA, Colcol E, Sahovic E, Aljurf M, Gyger M.
    Bone Marrow Transplant; 2002 Aug 16; 30(3):189-94. PubMed ID: 12189538
    [Abstract] [Full Text] [Related]

  • 14. Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation.
    Knöll A, Boehm S, Hahn J, Holler E, Jilg W.
    Bone Marrow Transplant; 2004 May 16; 33(9):925-9. PubMed ID: 15004543
    [Abstract] [Full Text] [Related]

  • 15. Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT.
    Viganò M, Vener C, Lampertico P, Annaloro C, Pichoud C, Zoulim F, Facchetti F, Poli F, Scalamogna M, Deliliers GL, Colombo M.
    Bone Marrow Transplant; 2011 Jan 16; 46(1):125-31. PubMed ID: 20383209
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
    Yeo W, Chan TC, Leung NW, Lam WY, Mo FK, Chu MT, Chan HL, Hui EP, Lei KI, Mok TS, Chan PK.
    J Clin Oncol; 2009 Feb 01; 27(4):605-11. PubMed ID: 19075267
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH.
    J Pediatr Gastroenterol Nutr; 2009 Feb 01; 48(2):203-8. PubMed ID: 19179883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.